Paras Technology Platform

Paras Biopharmaceuticals Finland Oy offers a wide spectrum of biopharmaceuticals technologies for therapeutic peptides, proteins and process technologies.

Diabrid Technology is a unique propriety technology for the expression of recombinant therapeutic proteins and therapeutic peptides. The technology facilitates a higher expression of therapeutic proteins in a manner that enhances the quality and bio effectiveness of the molecules in addition to facilitating post production protocols.

This has successfully resulted in Paras Biopharmaceuticals Finland Oy being able to offer one of the most economical ways to improve the production of expensive biopharmaceuticals. Within Diabrid Expression Technology, Paras Biopharmaceuticals Finland Oy has incorporated a unique strategy to produce biologics including therapeutic proteins and therapeutic peptides in a way that overcomes the many limitations of traditional methods in the production of biopharmaceuticals.

Paras Biopharmaceuticals Finland Oy Offers

Company Presentation 2018

Company Presentation 2016

Company Presentation 2014

Company Presentation 2012

Meet Us At

Connect with us

Paras Biopharmaceuticals
Finland Oy
,

Kiviharjunlenkki 10, OULU,
FI-90220 Finland

P: +358 442709462

Dr Ashesh Kumar
E: kumar.ashesh@parasbiopharma.com
P: +358 (0) 400207380

Dr Upendra Khurana
E: upendra.khurana@parasbiopharma.com
P:+358 (0) 449783160

Dr Mark Jackson
E: mark.jackson@parasbiopharma.com
P:+358 (0) 442905993

Skype: Paras.Finland